Skip to Main Content


Skip Nav Destination


In This Issue

In the Spotlight

Cancer Hallmarks Reviews

Research Articles

Ivodesinib and venetoclax with or without azacitidine are safe and effective against IDH1-mutated myeloid cancers, with molecular correlates illustrating potential resistance-limiting mechanisms of combination therapy.

Hypusination of the eIF5A translation factor is necessary for the development and maintenance of MYC-driven lymphoma, where hypusinated eIF5A controls the translation of factors that are essential for cell-cycle transit and DNA replication.

A collection of iPSC lines derived from AML patients capture leukemia genomes and phenotypes and produce xenografts nearly identical to the matched primary PDXs. iPSCs from different AML clones uniquely empower the study of subclonal mutations.

Close Modal

or Create an Account

Close Modal
Close Modal